PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
96.98%
Some net income increase while AVGO is negative at -9.60%. John Neff would see a short-term edge over the struggling competitor.
3.13%
D&A growth well above AVGO's 2.44%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
179.92%
Deferred tax of 179.92% while AVGO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-9.32%
Negative yoy SBC while AVGO is 5.88%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
78.55%
Less working capital growth vs. AVGO's 300.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
55.09%
AR growth while AVGO is negative at -106.67%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-1937.56%
Both reduce yoy inventory, with AVGO at -42.86%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-4.14%
Negative yoy AP while AVGO is 205.88%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
110.36%
Growth well above AVGO's 121.74%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
644.85%
Well above AVGO's 150.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
2281.65%
Operating cash flow growth above 1.5x AVGO's 3.24%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-114.17%
Negative yoy CapEx while AVGO is 29.85%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
46.77%
Purchases growth of 46.77% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-19.08%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-237.96%
Both yoy lines negative, with AVGO at -211.11%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
74.72%
We have mild expansions while AVGO is negative at -10.53%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
3.69%
Debt repayment growth of 3.69% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-100.00%
Negative yoy issuance while AVGO is 80.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.